Emergency response plan puts DaVita in focus
DaVita (DVA) has triggered its emergency response plan as a severe storm approaches, aiming to keep dialysis treatments running and patients informed about backup centers, medical supplies, and preparedness steps in at risk regions.
Against that backdrop of emergency planning, DaVita’s share price has moved to US$182.08, with short term momentum softer after a roughly 21% decline over the past 90 days, even as the year to date share price return of 59% and three year total shareholder return of 138.39% point to a much stronger longer term run.
Scan beyond DaVita and identify other healthcare operators built for stress events using the 32 resilient stocks with low risk scores, which filters for resilient balance sheets and lower risk scores.
DaVita looks built to handle stress in the real world, yet the share price has surged this year before giving back about 21% over 90 days. Is the business strength still being valued sensibly at US$182.08?
Most Popular Narrative: 17% Undervalued
DaVita’s most followed narrative points to a fair value of $219.86 compared with the latest close at $182.08, implying investors are pricing in a discount even after a strong multi year share price run.
The Integrated Kidney Care business is achieving the highest aggregate savings in its CMS program with improved quality scores and is expected to add roughly US$20 million of adjusted operating income growth in 2026 and around 1 percentage point of ongoing operating income contribution, which can support DaVita’s earnings even if U.S. dialysis reimbursement remains tight.
See why 20 investors see DaVita as 17% undervalued.
Result: Fair Value of $219.86 (UNDERVALUED)
Still, DaVita’s story can break if reimbursement updates continue to trail rising costs, or if shifts in payer mix reduce revenue per treatment more sharply than expected.
Find out about the key risks to this DaVita narrative.
Next Steps
Opinions on DaVita are split between concern and optimism, so consider acting promptly and review the balance for yourself by examining the 3 key rewards and 1 important warning sign.
Looking for more investment ideas beyond DaVita?
If DaVita has your attention today, do not stop there. Broaden your watchlist with fresh ideas that match your risk, income, and value priorities.
- Spot potential bargains early by scanning companies that look mispriced on quality and valuation using the 32 high quality undervalued stocks.
- Strengthen your income stream by focusing on companies that aim to pair higher yields with resilience through the 8 dividend fortresses.
- Protect your capital first by concentrating on businesses with robust finances and consistent metrics via the list of solid balance sheet and fundamentals (25 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com